Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pietro Invernizzi

Showing results (321-330 of 420) with videos related to

Pageof 42
Sort By:
Alimentary Pharmacology & Therapeutics|September 22, 2025
Non-Response to Obeticholic Acid Is Associated With Heightened Risks of Developing Clinical Events in Primary Biliary CholangitisNadir Abbas, Rachel Smith, Ellina Lytvyak, et al.
Journal of Translational Autoimmunity|February 8, 2021
Quality of life in patients with primary biliary cholangitis: A cross-geographical comparisonLorenzo Montali, Andrea Gragnano, Massimo Miglioretti, et al.
Hepatology (Baltimore, Md.)|July 26, 2019
Modulation of the Tryptophan Hydroxylase 1/Monoamine Oxidase-A/5-Hydroxytryptamine/5-Hydroxytryptamine Receptor 2A/2B/2C Axis Regulates Biliary Proliferation and Liver Fibrosis During CholestasisKonstantina Kyritsi, Lixian Chen, April O'Brien, et al.
Hepatology (Baltimore, Md.)|April 14, 2011
Epithelial cell specificity and apotope recognition by serum autoantibodies in primary biliary cirrhosisGuanghua Rong, Renqian Zhong, Ana Lleo, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 2, 2026
Seronegative Autoimmune Hepatitis in Adults Is a Rare Entity Often Obscured by Suboptimal Diagnostic AssessmentFrancesca Colapietro, Charlotte D Slooter, Kalliopi Zachou, et al.
Journal of Hepatology|June 12, 2020
High rates of 30-day mortality in patients with cirrhosis and COVID-19Massimo Iavarone, Roberta D'Ambrosio, Alessandro Soria, et al.
ACS Nano|March 19, 2019
Dexamethasone Conjugation to Biodegradable Avidin-Nucleic-Acid-Nano-Assemblies Promotes Selective Liver Targeting and Improves Therapeutic Efficacy in an Autoimmune Hepatitis Murine ModelMartina Bruna Violatto, Elisabetta Casarin, Laura Talamini, et al.
Cambridge Prisms. Precision Medicine|March 29, 2024
Making inroads to precision medicine for the treatment of autoimmune diseases: Harnessing genomic studies to better diagnose and treat complex disordersYuriy Baglaenko, Catriona Wagner, Vijay G Bhoj, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 2, 2020
Endoscopic Findings in Patients Infected With 2019 Novel Coronavirus in Lombardy, ItalySara Massironi, Chiara Viganò, Lorenzo Dioscoridi, et al.
Clinical and Translational Science|September 15, 2021
Safety and clinical efficacy of the double switch from originator infliximab to biosimilars CT-P13 and SB2 in patients with inflammatory bowel diseases (SCESICS): A multicenter cohort studyStefano Mazza, Nicole Piazza O Sed, Francesco Simone Conforti, et al.
Pageof 42

Showing results (321-330 of 420) with videos related to

Sort By:
Pageof 42
Alimentary Pharmacology & Therapeutics|September 22, 2025
Non-Response to Obeticholic Acid Is Associated With Heightened Risks of Developing Clinical Events in Primary Biliary CholangitisNadir Abbas, Rachel Smith, Ellina Lytvyak, et al.
Journal of Translational Autoimmunity|February 8, 2021
Quality of life in patients with primary biliary cholangitis: A cross-geographical comparisonLorenzo Montali, Andrea Gragnano, Massimo Miglioretti, et al.
Hepatology (Baltimore, Md.)|July 26, 2019
Modulation of the Tryptophan Hydroxylase 1/Monoamine Oxidase-A/5-Hydroxytryptamine/5-Hydroxytryptamine Receptor 2A/2B/2C Axis Regulates Biliary Proliferation and Liver Fibrosis During CholestasisKonstantina Kyritsi, Lixian Chen, April O'Brien, et al.
Hepatology (Baltimore, Md.)|April 14, 2011
Epithelial cell specificity and apotope recognition by serum autoantibodies in primary biliary cirrhosisGuanghua Rong, Renqian Zhong, Ana Lleo, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 2, 2026
Seronegative Autoimmune Hepatitis in Adults Is a Rare Entity Often Obscured by Suboptimal Diagnostic AssessmentFrancesca Colapietro, Charlotte D Slooter, Kalliopi Zachou, et al.
Journal of Hepatology|June 12, 2020
High rates of 30-day mortality in patients with cirrhosis and COVID-19Massimo Iavarone, Roberta D'Ambrosio, Alessandro Soria, et al.
ACS Nano|March 19, 2019
Dexamethasone Conjugation to Biodegradable Avidin-Nucleic-Acid-Nano-Assemblies Promotes Selective Liver Targeting and Improves Therapeutic Efficacy in an Autoimmune Hepatitis Murine ModelMartina Bruna Violatto, Elisabetta Casarin, Laura Talamini, et al.
Cambridge Prisms. Precision Medicine|March 29, 2024
Making inroads to precision medicine for the treatment of autoimmune diseases: Harnessing genomic studies to better diagnose and treat complex disordersYuriy Baglaenko, Catriona Wagner, Vijay G Bhoj, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 2, 2020
Endoscopic Findings in Patients Infected With 2019 Novel Coronavirus in Lombardy, ItalySara Massironi, Chiara Viganò, Lorenzo Dioscoridi, et al.
Clinical and Translational Science|September 15, 2021
Safety and clinical efficacy of the double switch from originator infliximab to biosimilars CT-P13 and SB2 in patients with inflammatory bowel diseases (SCESICS): A multicenter cohort studyStefano Mazza, Nicole Piazza O Sed, Francesco Simone Conforti, et al.
Pageof 42